
{
    "Variants Include": [
        {
            "Gene": "SNCA",
            "variants": [
                {
                    "HGVS": "NM_000345.4:c.88G>C",
                    "cDNA Change": {
                        "transcript": "NM_000345.4",
                        "ref": "G",
                        "alt": "C",
                        "position": "88"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "P",
                        "position": "30"
                    },
                    "Description in input context": "A30P"
                },
                {
                    "HGVS": "NM_000345.4:c.136G>A",
                    "cDNA Change": {
                        "transcript": "NM_000345.4",
                        "ref": "G",
                        "alt": "A",
                        "position": "136"
                    },
                    "Protein Change": {
                        "ref": "E",
                        "alt": "K",
                        "position": "46"
                    },
                    "Description in input context": "E46K"
                },
                {
                    "HGVS": "NM_000345.4:c.157G>A",
                    "cDNA Change": {
                        "transcript": "NM_000345.4",
                        "ref": "G",
                        "alt": "A",
                        "position": "157"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "T",
                        "position": "53"
                    },
                    "Description in input context": "A53T"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson disease",
        "MONDO": "MONDO:0005180"
    },
    "Experiment Method": [
        {
            "Assay Method": "In vitro degradation assay",
            "Material used": {
                "Material Source": "Purified proteins",
                "Material Name": "20S proteasome, αSyn proteins",
                "Description": "20S proteasome was purified from bovine red blood cells and αSyn proteins were expressed and purified."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.88G>C",
                    "Conclusion": "Normal",
                    "Molecular Effect": "No effect",
                    "Result Description": "there are no dramatic differences in the rate of degradation of full-length wild-type, A53T-syn, and A30P-syn"
                },
                {
                    "Variant": "NM_000345.4:c.136G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The E46K mutation led to rapid turnover of full-length αSyn and produced a different fragmentation pattern with the 1–73 fragment appearing early."
                },
                {
                    "Variant": "NM_000345.4:c.157G>A",
                    "Conclusion": "Normal",
                    "Molecular Effect": "No effect",
                    "Result Description": "there are no dramatic differences in the rate of degradation of full-length wild-type, A53T-syn, and A30P-syn"
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wildtype αSyn was used as the basic positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Reactions with 20S proteasome preincubated with the inhibitor MG132 served as basic negative controls."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "αSyn oligomerization assays",
            "Material used": {
                "Material Source": "Purified proteins",
                "Material Name": "αSyn proteins",
                "Description": "100 μM recombinant αSyn protein was incubated in 20 mM phosphate buffer (pH 7.2) at 37°C with shaking. Where indicated, 20S proteasome and/or liposomes were also included in the incubation mixture."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.88G>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "Oligomers of A30P-syn were only observed when both 20S and liposomes were present."
                },
                {
                    "Variant": "NM_000345.4:c.136G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "E46K-syn readily produced oligomers in the presence of 20S, liposomes, or both, and oligomers were observed even when E46K-syn was alone."
                },
                {
                    "Variant": "NM_000345.4:c.157G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "A53T-syn readily produced oligomers in the presence of 20S, liposomes, or both, and oligomers were observed even when A53T-syn was alone."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wildtype αSyn was used as the basic positive control, and it produced small amounts of oligomers when incubated with both 20S proteasome and liposomes."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}